Cytokines and TLR agonists influence the expression of retention integrins CD49a, CD49b and CD103 by T cells by Marit M Melssen et al.
POSTER PRESENTATION Open Access
Cytokines and TLR agonists influence the
expression of retention integrins CD49a, CD49b
and CD103 by T cells
Marit M Melssen*, Ciara Hutchison, Ileana S Mauldin, Timothy N Bullock, Craig L Slingluff
From 30th Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer
(SITC 2015)
National Harbor, MD, USA. 4-8 November 2015
T cell infiltration in the tumor microenvironment (TME)
is positively correlated with survival. Infiltration is not a
stable state, but a dynamic process of homing, infiltration,
retention and survival. Every step in this process is crucial
for the eventual tumor reactive activity of T cells. Our
laboratory has previously shown a marked upregulation of
retention integrins (RI) CD49a, CD49b and CD103 on
tumor infiltrating lymphocytes (TIL) in melanoma. T cells
in peripheral tissues expressing RI appear to have a cyto-
toxic phenotype and RI+ TIL are associated with improved
patient survival. Despite their importance in retention of
tumor reactive TILs, little is known about pathways indu-
cing RI expression, except that TGFb induces CD103. We
hypothesized that other cytokines, TLR agonists and T cell
receptor (TCR) stimulation can induce RI expression by
circulating T cells. PBMCs were grown in presence of
cytokines after TCR stimulation and RI expression was
evaluated by flow cytometry after 2-7 days. Both CD103
and CD49a are induced by TGFb, most strikingly on acti-
vated T cells. IL2 and IL10 also influence CD49a expres-
sion. CD49b expression is increased by IL2, IL4 and IL10,
although this depends on T cell subset and activation
state. TLR2, TLR6 and TLR7 agonists appear to induce
CD49a and CD49b as well. In addition we have found that
IL2 and TGFb upregulate RI expression on T cells with
different proliferation rates and cytotoxic activity. In con-
clusion, above results support our hypothesis by showing
that RI expression is tightly regulated by cytokine and
TCR stimulation. Interestingly, the regulating factors have
different effects among the RI and phenotype of RI+
T cells. Which suggests a different role for each of the RI
and a substantial contribution of the induction route in
the determination of this role. Furthermore the cytokines
found to be involved with RI expression are associated
with either Th1, Th2 or Treg cells. All raising interesting
questions about the features of the TME that best support
tumor reactive T cell retention in the tumor.
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